Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype
Open Access
- 20 August 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Bio & Med Chem Au
- Vol. 1 (1), 21-30
- https://doi.org/10.1021/acsbiomedchemau.1c00024
Abstract
No abstract availableKeywords
Funding Information
- William K. Warren Foundation (GET300064)
This publication has 28 references indexed in Scilit:
- Drugs for Allosteric Sites on ReceptorsAnnual Review of Pharmacology and Toxicology, 2014
- Profound Methyl Effects in Drug Discovery and a Call for New C-H Methylation ReactionsAngewandte Chemie, 2013
- Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu3 Selective and CNS Penetrant Negative Allosteric Modulator (NAM)Journal of Medicinal Chemistry, 2013
- Methyl Effects on Protein–Ligand BindingJournal of Medicinal Chemistry, 2012
- Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug DiscoveryJournal of Medicinal Chemistry, 2011
- “Molecular Switches” on mGluR Allosteric Ligands That Modulate Modes of PharmacologyBiochemistry, 2011
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and DiseaseAnnual Review of Pharmacology and Toxicology, 2010
- Discovery of Molecular Switches That Modulate Modes of Metabotropic Glutamate Receptor Subtype 5 (mGlu5) Pharmacology in Vitro and in Vivo within a Series of Functionalized, Regioisomeric 2- and 5-(Phenylethynyl)pyrimidinesJournal of Medicinal Chemistry, 2009
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersNature Reviews Drug Discovery, 2009
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988